Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hereditary liver diseases].

H C Spangenberg1, K Rösler, H E Blum

  • 1Medizinische Universitätsklinik, Abteilung Innere Medizin II, Albert-Ludwigs-Universität, Freiburg. spangenberg@ukl.uni-freiburg.de

Therapeutische Umschau. Revue Therapeutique
|October 2, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience.

European journal of neurology·2017
Same author

The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice.

Cell death and differentiation·2015
Same author

Editorial: TIPSS in patients with cirrhosis and hepatocellular carcinoma - authors' reply.

Alimentary pharmacology & therapeutics·2014
Same author

Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma.

Alimentary pharmacology & therapeutics·2014
Same author

[Stimulus-triggered acquisition of pluripotency: a new perspective in reprogramming of differentiated somatic cells].

Deutsche medizinische Wochenschrift (1946)·2014
Same author

[Sofosbuvir: alternative in hepatitis C infection?].

Deutsche medizinische Wochenschrift (1946)·2013
Same journal

[Multimodal Cardiac Imaging: New Developments for Clinical Practice].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Coronary angiography: From cardiac catheterization to advanced interventional cardiovascular imaging].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Athlete's heart: role of cardiac imaging in the prevention of sudden cardiac death].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Multimodal imaging in cardiac amyloidosis and cardiac sarcoidosis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

[Inflammatory Heart Disease: The Role of Multimodality Cardiac Imaging in Myocarditis and Pericarditis].

Therapeutische Umschau. Revue therapeutique·2026
Same journal

State-of-the-Art Cardiac Imaging

Therapeutische Umschau. Revue therapeutique·2026
See all related articles

This review covers common hereditary liver diseases, including hereditary hemochromatosis, Wilson's disease, and alpha1-antitrypsin deficiency. It details their clinical signs, diagnostic methods, and treatments, despite genetic testing

Area of Science:

  • Hepatology
  • Medical Genetics
  • Molecular Biology

Background:

  • Hereditary liver diseases are increasingly understood through gene defect identification.
  • Hereditary hemochromatosis, Wilson's disease, and alpha1-antitrypsin deficiency are prevalent genetic liver conditions.
  • Pathogenesis of these diseases is better elucidated by characterizing underlying gene defects.

Purpose of the Study:

  • To review the clinical manifestations, diagnosis, and therapy of common hereditary liver diseases.
  • To provide a comprehensive overview of hereditary hemochromatosis, Wilson's disease, and alpha1-antitrypsin deficiency.
  • To consolidate current knowledge on managing these frequent genetic liver disorders.

Main Methods:

  • Literature review of hereditary hemochromatosis, Wilson's disease, and alpha1-antitrypsin deficiency.

Related Experiment Videos

  • Synthesis of clinical data, diagnostic approaches, and therapeutic strategies.
  • Analysis of the correlation between gene defects and disease presentation.

    • Main Results:

    • Hereditary hemochromatosis, Wilson's disease, and alpha1-antitrypsin deficiency are the most common genetic liver diseases.
    • Clinical manifestations vary, and genetic testing often does not aid diagnosis.
    • Understanding gene defects improves insight into disease pathogenesis.

    Conclusions:

    • Effective management relies on recognizing clinical signs and applying appropriate diagnostic and therapeutic strategies.
    • Despite advances in genetic identification, clinical assessment remains crucial for diagnosis.
    • This review offers a consolidated guide to the most frequent hereditary liver diseases.